124 related articles for article (PubMed ID: 15214593)
1. Monoclonal antibodies: the foundation of therapy for colorectal cancer in the 21st century?
Hoff PM; Ellis LM; Abbruzzese JL
Oncology (Williston Park); 2004 May; 18(6):736-41; discussion 742, 745-6. PubMed ID: 15214593
[TBL] [Abstract][Full Text] [Related]
2. [Antibody treatment in colorectal cancer--what the surgeon needs to know].
Thalheimer A; Illert B; Reimer P; Bueter M; Thiede A; Gasser M; Fein M; Waaga-Gasser AM; Meyer D
Zentralbl Chir; 2008 Apr; 133(2):101-6. PubMed ID: 18415895
[TBL] [Abstract][Full Text] [Related]
3. Antivascular endothelial growth factor monoclonal antibody therapy: a promising paradigm in colorectal cancer.
Franson PJ; Lapka DV
Clin J Oncol Nurs; 2005 Feb; 9(1):55-60. PubMed ID: 15751499
[TBL] [Abstract][Full Text] [Related]
4. Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report.
Nygren P; Sørbye H; Osterlund P; Pfeiffer P
Acta Oncol; 2005; 44(3):203-17. PubMed ID: 16076691
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
6. Targeted therapy in colorectal cancer.
Rajpal S; Venook AP
Clin Adv Hematol Oncol; 2006 Feb; 4(2):124-32. PubMed ID: 16728921
[TBL] [Abstract][Full Text] [Related]
7. [Some problems facing the molecular targeting therapy for colorectal cancer].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):321-3. PubMed ID: 19799077
[No Abstract] [Full Text] [Related]
8. Cetuximab in the treatment of colorectal cancer.
Ciardiello F; De Vita F; Orditura M; Comunale D; Galizia G
Future Oncol; 2005 Apr; 1(2):173-81. PubMed ID: 16555987
[TBL] [Abstract][Full Text] [Related]
9. Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer.
Morse MA
IDrugs; 2005 Dec; 8(12):974-7. PubMed ID: 16320126
[No Abstract] [Full Text] [Related]
10. Clinical use of anti-vascular endothelial growth factor monoclonal antibodies in metastatic colorectal cancer.
Chase JL
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):23S-30S. PubMed ID: 18980549
[TBL] [Abstract][Full Text] [Related]
11. Targeting angiogenesis in cancer: clinical development of bevacizumab.
Kerr DJ
Nat Clin Pract Oncol; 2004 Nov; 1(1):39-43. PubMed ID: 16264798
[TBL] [Abstract][Full Text] [Related]
12. Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.
Pohl A; Zhang W; Ning Y; Manegold PC; Lurje G; Lenz HJ
Oncology (Williston Park); 2008 Apr; 22(4):456-62; discussion 462-3, 467-8, 474 passim. PubMed ID: 18472617
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies in the treatment of advanced colorectal cancer.
Capdevila J; Saura C; Macarulla T; Casado E; Ramos FJ; Tabernero J
Eur J Surg Oncol; 2007 Dec; 33 Suppl 2():S24-34. PubMed ID: 17981431
[TBL] [Abstract][Full Text] [Related]
14. Current issues in the targeted therapy of advanced colorectal cancer.
Knijn N; Tol J; Punt CJ
Discov Med; 2010 Apr; 9(47):328-36. PubMed ID: 20423677
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy in colorectal cancer: do we know enough?
Pantaleo MA; Palassini E; Labianca R; Biasco G
Dig Liver Dis; 2006 Feb; 38(2):71-7. PubMed ID: 16289975
[TBL] [Abstract][Full Text] [Related]
16. Biologic therapy for colon cancer.
He AR; Marshall J
Clin Adv Hematol Oncol; 2005 Jul; 3(7):555-61. PubMed ID: 16167038
[TBL] [Abstract][Full Text] [Related]
17. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
Engstrom PF;
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):18S-22S. PubMed ID: 18980548
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.
Goldberg RM; Hurwitz HI; Fuchs CS
Clin Adv Hematol Oncol; 2005 Dec; 3(12):1-10; quiz 11. PubMed ID: 16555433
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer.
Winder T; Lenz HJ
Gastroenterology; 2010 Jun; 138(6):2163-76. PubMed ID: 20420953
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab and cetuximab for colorectal cancer.
Drug Ther Bull; 2006 May; 44(5):37-40. PubMed ID: 16706233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
